Laboratoire de génétique moléculaire, Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, H2W 1R7, Canada.
Departments of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX2 6HS, UK.
Nat Commun. 2019 Sep 3;10(1):3960. doi: 10.1038/s41467-019-11894-3.
Translation is a basic cellular process and its capacity is adapted to cell function. In particular, secretory cells achieve high protein synthesis levels without triggering the protein stress response. It is unknown how and when translation capacity is increased during differentiation. Here, we show that the transcription factor Creb3l2 is a scaling factor for translation capacity in pituitary secretory cells and that it directly binds ~75% of regulatory and effector genes for translation. In parallel with this cell-autonomous mechanism, implementation of the physiological UPR pathway prevents triggering the protein stress response. Knockout mice for Tpit, a pituitary differentiation factor, show that Creb3l2 expression and its downstream regulatory network are dependent on Tpit. Further, Creb3l2 acts by direct targeting of translation effector genes in parallel with signaling pathways that otherwise regulate protein synthesis. Expression of Creb3l2 may be a useful means to enhance production of therapeutic proteins.
翻译是一种基本的细胞过程,其能力适应细胞功能。特别是,分泌细胞在不引发蛋白质应激反应的情况下实现高水平的蛋白质合成。目前尚不清楚在分化过程中如何以及何时增加翻译能力。在这里,我们表明转录因子 Creb3l2 是垂体分泌细胞翻译能力的缩放因子,它直接结合了约 75%的翻译调节和效应基因。与这种细胞自主机制平行的是,生理 UPR 途径的实施可防止触发蛋白质应激反应。pituitary 分化因子 Tpit 的敲除小鼠表明,Creb3l2 的表达及其下游调节网络依赖于 Tpit。此外,Creb3l2 通过直接靶向翻译效应基因与调节蛋白质合成的信号通路平行作用。Creb3l2 的表达可能是增强治疗性蛋白质生产的一种有用手段。